# Revelation Biosciences, Inc.: filings

REVB · Nasdaq · CIK 1810560 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/revb.md) · [Financials](/companies/revb/financials.md) · [Filings](/companies/revb/filings.md) · [Insiders](/companies/revb/insiders.md)

## Reports and events: 160 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 96, 4 51, CORRESP 26, 10-Q 18, 3 17, UPLOAD 16, SC 13G/A 15, EFFECT 14, SC 13G 14, S-1/A 13, 424B3 11, DEF 14A 11, PRE 14A 11, S-1 8, DEFA14A 7, 10-K 6, 425 5, S-3 5, S-8 5, SCHEDULE 13G/A 4, 8-K/A 3, NT 10-Q 3, S-4/A 3, SCHEDULE 13G 3, 10-K/A 2, 10-Q/A 2, 8-A12B 2, DRS 2, S-3/A 2, 144 1, 25-NSE 1, 424B4 1, 4/A 1, 5 1, ARS 1, CERT 1, DEFR14A 1, NT 10-K 1, S-1MEF 1, S-4 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-19 | 17:07 ET | [8-K](/filings/0001193125-26-357120.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-357120 |
| 2026-08-06 | 16:19 ET | [8-K](/filings/0001193125-26-338097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338097 |
| 2026-08-06 | 16:07 ET | [10-Q](/filings/0001193125-26-337967.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337967 |
| 2026-07-13 | 16:05 ET | [8-K](/filings/0001193125-26-302008.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-302008 |
| 2026-06-24 | 16:47 ET | [8-K](/filings/0001193125-26-281200.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-281200 |
| 2026-06-01 | 17:26 ET | [8-K](/filings/0001193125-26-251784.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-251784 |
| 2026-05-11 | 09:56 ET | [DEF 14A](/filings/0001193125-26-215804.md) | Proxy statement, period 2026-06-24 | 0001193125-26-215804 |
| 2026-05-07 | 16:23 ET | [8-K](/filings/0001193125-26-212064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-212064 |
| 2026-05-07 | 16:06 ET | [10-Q](/filings/0001193125-26-211871.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211871 |
| 2026-03-19 | 16:18 ET | [8-K](/filings/0001193125-26-116012.md) | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-116012 |
| 2026-02-26 | 16:25 ET | [8-K](/filings/0001193125-26-076833.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076833 |
| 2026-02-26 | 16:06 ET | [10-K](/filings/0001193125-26-076552.md) | Annual report, period 2025-12-31 | 0001193125-26-076552 |
| 2026-02-17 | 12:35 ET | [DEF 14A](/filings/0001193125-26-053984.md) | Proxy statement, period 2026-02-14 | 0001193125-26-053984 |
| 2026-01-29 | 18:46 ET | [8-K](/filings/0001193125-26-027742.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-027742 |
| 2026-01-22 | 19:01 ET | [8-K](/filings/0001193125-26-018332.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-018332 |
| 2025-12-03 | 17:01 ET | [8-K](/filings/0001193125-25-306915.md) | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-306915 |
| 2025-11-10 | 14:57 ET | [DEF 14A](/filings/0001193125-25-273712.md) | Proxy statement, period 2025-12-03 | 0001193125-25-273712 |
| 2025-11-06 | 16:28 ET | [8-K](/filings/0001193125-25-269696.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269696 |
| 2025-11-06 | 16:03 ET | [10-Q](/filings/0001193125-25-269450.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269450 |
| 2025-10-29 | 16:20 ET | [8-K](/filings/0001193125-25-256367.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-256367 |
| 2025-10-15 | 17:06 ET | [8-K](/filings/0001193125-25-240400.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-240400 |
| 2025-09-22 | 16:15 ET | [DEF 14A](/filings/0001193125-25-211333.md) | Proxy statement, period 2025-09-22 | 0001193125-25-211333 |
| 2025-09-15 | 17:02 ET | [8-K](/filings/0001193125-25-203750.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203750 |
| 2025-09-09 | 08:02 ET | [8-K](/filings/0001810560-25-000006.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001810560-25-000006 |
| 2025-08-08 | 08:10 ET | [8-K](/filings/0000950170-25-105485.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105485 |
| 2025-08-08 | 18:05 ET | [10-Q](/filings/0000950170-25-105284.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105284 |
| 2025-07-09 | 16:17 ET | [8-K](/filings/0000950170-25-094789.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-094789 |
| 2025-06-25 | 16:26 ET | [8-K](/filings/0000950170-25-089972.md) | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-25-089972 |
| 2025-06-09 | 16:51 ET | [DEF 14A](/filings/0000950170-25-083815.md) | Proxy statement, period 2025-05-29 | 0000950170-25-083815 |
| 2025-06-04 | 16:05 ET | [8-K](/filings/0000950170-25-081604.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-081604 |
| 2025-05-28 | 16:14 ET | [8-K](/filings/0000950170-25-078340.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000950170-25-078340 |
| 2025-05-23 | 09:56 ET | [S-1/A](/filings/0001213900-25-047104.md) | Registration statement, amended | 0001213900-25-047104 |
| 2025-05-20 | 14:20 ET | [S-1](/filings/0001213900-25-045828.md) | Registration statement | 0001213900-25-045828 |
| 2025-05-08 | 16:21 ET | [8-K](/filings/0000950170-25-067043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067043 |
| 2025-05-08 | 16:02 ET | [10-Q](/filings/0000950170-25-066897.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066897 |
| 2025-03-17 | 16:17 ET | [8-K](/filings/0000950170-25-040294.md) | 8.01 Other events | 0000950170-25-040294 |
| 2025-03-06 | 16:19 ET | [8-K](/filings/0000950170-25-034689.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034689 |
| 2025-03-06 | 16:03 ET | [10-K](/filings/0000950170-25-034584.md) | Annual report, period 2024-12-31 | 0000950170-25-034584 |
| 2025-02-24 | 16:12 ET | [8-K](/filings/0000950170-25-025626.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-025626 |
| 2025-02-11 | 16:05 ET | [8-K](/filings/0000950170-25-017882.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-017882 |
| 2025-01-30 | 17:19 ET | [8-K](/filings/0000950170-25-011197.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-011197 |
| 2025-01-21 | 16:31 ET | [8-K](/filings/0000950170-25-007303.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-007303 |
| 2025-01-07 | 16:05 ET | [8-K](/filings/0000950170-25-002828.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-002828 |
| 2024-12-16 | 08:54 ET | [DEF 14A](/filings/0000950170-24-136402.md) | Proxy statement, period 2024-12-13 | 0000950170-24-136402 |
| 2024-12-12 | 17:20 ET | [8-K](/filings/0000950170-24-135895.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135895 |
| 2024-12-06 | 16:03 ET | [8-K](/filings/0000950170-24-134064.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134064 |
| 2024-11-08 | 16:25 ET | [8-K](/filings/0000950170-24-124141.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124141 |
| 2024-11-08 | 16:00 ET | [10-Q](/filings/0000950170-24-124036.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124036 |
| 2024-10-21 | 16:19 ET | [8-K](/filings/0000950170-24-115955.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-24-115955 |
| 2024-09-27 | 16:09 ET | [8-K](/filings/0000950170-24-109998.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-109998 |

Page 1 of 4. [Older](/companies/revb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.